Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Sun

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 23, 2020
HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patientsJ H Shim, H S Kim, H Cha, et al.
Molecular Cell|August 14, 1998
SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factorsC D Laherty, A N Billin, R M Lavinsky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2013
Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancerS Park, I R Kim, K K Baek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 18, 2013
Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancerJ-M Sun, Y C Ahn, E K Choi, et al.
Epidemiology and Infection|May 29, 2014
Seroprevalence of severe fever with thrombocytopenia syndrome virus in southeastern China and analysis of risk factorsJ M Sun, Y J Zhang, Z Y Gong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 25, 2014
A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancerS H Lim, J Y Lee, M-Y Lee, et al.
ESMO Open|November 19, 2025
Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 studyJ-P Metges, K Kato, J-M Sun, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 23, 2020
HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patientsJ H Shim, H S Kim, H Cha, et al.
Molecular Cell|August 14, 1998
SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factorsC D Laherty, A N Billin, R M Lavinsky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2013
Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancerS Park, I R Kim, K K Baek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 18, 2013
Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancerJ-M Sun, Y C Ahn, E K Choi, et al.
Epidemiology and Infection|May 29, 2014
Seroprevalence of severe fever with thrombocytopenia syndrome virus in southeastern China and analysis of risk factorsJ M Sun, Y J Zhang, Z Y Gong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 25, 2014
A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancerS H Lim, J Y Lee, M-Y Lee, et al.
ESMO Open|November 19, 2025
Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 studyJ-P Metges, K Kato, J-M Sun, et al.
Pageof 10